Cart
sales@molnova.com
N-Boc-Phe-Leu-Phe-Leu-Phe
CAS No. 148182-34-7
N-Boc-Phe-Leu-Phe-Leu-Phe( —— )
Catalog No. M29911 CAS No. 148182-34-7
N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 71 | In Stock |
|
| 5MG | 110 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 350 | In Stock |
|
| 50MG | 516 | In Stock |
|
| 100MG | 734 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Boc-Phe-Leu-Phe-Leu-Phe
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
-
DescriptionN-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFPR1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number148182-34-7
-
Formula Weight785.97
-
Molecular FormulaC44H59N5O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (127.23 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CFTR (108-117), Pseu...
CFTR (108-117), Pseudomonas aeruginosa Inhibitor
-
Angeloylgomisin O
Angeloylgomisin O is a nartural product from Schisandra chinensis.
-
KB-74935
KB-74935 is an enzyme inhibitor and a mineralocorticoid receptor antagonist used to treat cholesterol, hypolipidemia, neurological disorders, and Alzheimer's disease.
